Itonic Holdings Ltd. (NASDAQ:ITOC) Stock Short Interest Jumps 228.6%

Itonic Holdings Ltd. (NASDAQ:ITOC) saw a large increase in short interest during the month of September. As of September 30th, there was short interest totaling 206,400 shares, an increase of 228.6% from the September 15th total of 62,815 shares. Approximately 19.4% of the company’s stock are short sold. Based on an average daily trading volume, of 1,701,703 shares, the days-to-cover ratio is currently 0.1 days.

Itonic Stock Performance

Shares of ITOC stock traded down $0.49 during trading hours on Monday, hitting $3.58. 24,939 shares of the company were exchanged, compared to its average volume of 68,475. Itonic has a one year low of $3.42 and a one year high of $18.40. The business’s 50-day simple moving average is $4.66 and its two-hundred day simple moving average is $4.95.

Itonic (NASDAQ:ITOC) last released its earnings results on Wednesday, September 30th. The company reported ($0.75) EPS for the quarter. The business had revenue of $0.05 million during the quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of Itonic from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, September 24th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

About Itonic

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.